Update on NTEP
Now I have enough grounded facts. Writing the study note.
Update on NTEP — i-DRONE Initiative Cuts TB Diagnosis Time & Costs
1. At a Glance
- National TB Elimination Programme (NTEP) is India's flagship programme to eliminate TB before the global 2030 target; latest update showcases tech-enabled diagnostics via drones [S1].
- ICMR's i-DRONE initiative, piloted for TB sputum sample transport in a remote Telangana district, cut diagnosis turnaround time by two-thirds and patient costs by over 99% [S1].
- Relevant for Prelims (programme nomenclature, numbers) and Mains GS-II (health governance) / GS-III (S&T application in public health).
2. Why in the News
- 4 August 2026: PIB released "Update on NTEP," reporting an ICMR study (under i-DRONE) showing drone-assisted TB sputum sample transport reduced median diagnosis turnaround from 15 days to 5 days, and mean patient out-of-pocket expenditure from ₹9,451 to ₹91 [S1].
- Study conducted in Yadadri-Bhuvanagiri district, Telangana, in collaboration with AIIMS Bibinagar and NTEP [S1].
- Statement issued by Smt. Anupriya Patel, Union Minister of State for Health and Family Welfare [S1].
3. Background & Evolution
- 1962: National Tuberculosis Programme (NTP) launched.
- 1997: Revamped as Revised National Tuberculosis Control Programme (RNTCP), adopting WHO's DOTS strategy.
- 2020: RNTCP renamed National TB Elimination Programme (NTEP) to align with India's target of eliminating TB before the global 2030 deadline [S3].
- National Strategic Plan for TB Elimination (2017–25) guides implementation under NHM [S3].
- i-DRONE: originally launched by ICMR (with Shri Mansukh Mandaviya) for drone-based COVID-19 vaccine delivery to remote regions; since scaled to blood bags, corneas, and now TB sputum samples [S4].
- 7 December 2024: 100-Day TB Elimination Campaign launched by Shri J.P. Nadda in Panchkula, Haryana, covering 347 high-burden districts across 33 States/UTs [S2].
4. Core Static Facts
| Item | Detail |
|---|---|
| Nodal Ministry | Ministry of Health & Family Welfare (MoHFW) [S1] |
| Implementing framework | National Health Mission (NHM) [S3] |
| Research body | Indian Council of Medical Research (ICMR) [S1] |
| Target | Eliminate TB before global target of 2030 [S3] |
| Study site | Yadadri-Bhuvanagiri district, Telangana [S1] |
| Study partners | AIIMS Bibinagar, NTEP [S1] |
| Diagnosis time (pre-drone) | 15 days (median) [S1] |
| Diagnosis time (with drone) | 5 days (median) [S1] |
| Patient cost (pre-drone) | ₹9,451 (mean out-of-pocket) [S1] |
| Patient cost (with drone) | ₹91 (mean out-of-pocket) [S1] |
| TB incidence decline (2015→2023) | 237 → 195 per lakh population (17.7% decline) [S3] |
| TB deaths decline (2015→2023) | 28 → 22 per lakh population (21.4% decline) [S3] |
| 100-Day Campaign screening | 12.97 crore vulnerable persons screened; 7.19 lakh TB cases detected (2.85 lakh asymptomatic) [S2] |
| Ni-kshay Mitras enrolled (as of 12 Nov 2025) | 6,77,541 individuals/organisations [S2] |
| India's share of global TB burden (WHO 2025) | ~25% (2.71 million estimated TB patients) [S5] |
5. Multi-Dimensional Analysis
Scientific / Technological - Drones overcome last-mile transport bottlenecks in hilly/forested/remote terrain where sample degradation and delay previously compromised diagnostic accuracy [S1]. - Extends i-DRONE's proven use-case portfolio (vaccines → blood bags → corneas → TB samples) into routine disease-programme logistics [S4].
Social - Sharp reduction in out-of-pocket expenditure (₹9,451→₹91) directly improves affordability and reduces catastrophic health expenditure for poor/tribal populations in remote districts [S1]. - Faster diagnosis reduces transmission window and improves treatment initiation for vulnerable groups screened under the 100-Day Campaign [S2].
Administrative - Model tested via Centre-State-institution convergence (ICMR + AIIMS Bibinagar + State NTEP machinery in Telangana), a template replicable across other high-burden/remote districts [S1]. - Success depends on drone regulatory clearance (DGCA/Ministry of Civil Aviation permissions already granted to ICMR) and cold-chain-grade sample handling [S1].
Economic - Reduced diagnostic delay lowers indirect costs (lost wages, repeat travel) and overall healthcare system burden from delayed TB treatment. - Potential to reduce programme cost of sample transport logistics in inaccessible terrain over time.
Governance - Reflects push toward technology-driven, data-backed public health interventions ahead of India's self-imposed 2025 TB elimination target (already lapsed relative to WHO's 2030 goal), signalling course correction via innovation [S3].
6. Recent Developments (last 12–18 months)
- 7 Dec 2024: 100-Day TB Mukt Bharat Abhiyaan launched; 347 districts covered [S2].
- 2024 calendar year: India notified over 26 lakh TB patients; 46,118+ Gram Panchayats awarded TB-free certification [S2].
- 24 March 2026: "India Speeding Towards TB Elimination" report released by MoHFW [S2].
- 12 Nov 2025: WHO flagged global funding challenges threatening TB response gains, including in high-burden countries like India [S6].
- 4 Aug 2026: PIB "Update on NTEP" on ICMR i-DRONE TB sample transport study results [S1].
- Since Dec 2024: over 20 crore vulnerable persons screened; 28 lakh+ TB patients diagnosed nationally under sustained campaign momentum [S2].
7. Prelims Hooks
- NTEP was earlier called RNTCP (Revised National Tuberculosis Control Programme), renamed in 2020 [S3].
- India's TB elimination target predates the global WHO End TB target of 2030.
- i-DRONE study site: Yadadri-Bhuvanagiri district, Telangana [S1].
- Study partner institution: AIIMS Bibinagar [S1].
- Median TB diagnosis turnaround time cut from 15 days to 5 days via drone transport [S1].
- Mean patient expenditure cut from ₹9,451 to ₹91 (>99% reduction) [S1].
- Statement on this study made by Anupriya Patel, MoS Health & Family Welfare [S1].
- NTEP functions under the National Health Mission (NHM) [S3].
- 100-Day TB Elimination Campaign launched on 7 December 2024 at Panchkula, Haryana by J.P. Nadda [S2].
- TB incidence in India declined 17.7% from 2015 to 2023 (237→195 per lakh) [S3].
- TB deaths declined 21.4% from 2015 to 2023 (28→22 per lakh) [S3].
- i-DRONE was originally launched for COVID-19 vaccine delivery, later expanded to blood bags, corneas, and now TB samples [S4].
- WHO Global TB Report 2025: India accounts for roughly 25% of global TB burden [S5].
- Nodal research agency for i-DRONE: ICMR (not NTEP directly; NTEP is the collaborating programme) [S1].
8. Mains Relevance
- GS-II: Health — Government policies/interventions for development in health sector; issues relating to poverty and hunger.
- GS-III: Science & Technology — applications of technology in governance/public health delivery; achievements of Indians in science.
- Possible question stems:
- "Discuss how drone technology is being leveraged to strengthen last-mile healthcare delivery in India, with reference to the National TB Elimination Programme." (GS-III)
- "Examine the socio-economic burden of tuberculosis on patients in remote areas and evaluate government measures to reduce out-of-pocket diagnostic costs." (GS-II)
- "India aims to eliminate TB ahead of the global 2030 target. Critically assess the pace of progress and the role of technological innovation in bridging implementation gaps." (GS-II/III)
9. Related Topics to Study Next
- TB Mukt Bharat Abhiyaan / Ni-kshay Mitra scheme — community participation model directly linked to NTEP delivery [S2].
- i-DRONE (broader ICMR drone programme) — same platform used for vaccines, blood, corneas; useful for comparative tech-in-health questions [S4].
- National Health Mission (NHM) — parent umbrella scheme housing NTEP.
- WHO End TB Strategy & Global TB Report — international benchmarking framework for India's targets [S5].
- Drone regulations in India (Civil Aviation Requirements, PLI for drones) — regulatory backbone enabling such pilots.
- Ayushman Bharat Digital Mission (ABDM) — parallel digital health infrastructure theme.
- One District One Product/telemedicine in remote/tribal health delivery — comparative last-mile delivery innovations.
10. Common Errors / Trap Areas
- Confusing NTEP with RNTCP: RNTCP was renamed to NTEP in 2020 — pre-2020 static facts referencing RNTCP are now outdated in current context.
- Attributing i-DRONE solely to TB — it is a multi-use ICMR drone platform (vaccines, blood, corneas, TB samples), not TB-specific.
- Mixing up the ₹9,451→₹91 cost figure with the 15→5 day time figure when recalling numbers under exam pressure.
- Assuming NTEP itself conducted the drone study — the lead research agency is ICMR, with NTEP and AIIMS Bibinagar as collaborators.
- Confusing India's self-set TB elimination target (before 2030) with the global WHO End TB Strategy target (2030) — they are aligned in direction but framed as India "ahead of" the global target.
11. Sources
- [S1] Update on NTEP — ICMR Study Finds Drone-Assisted TB Sample Transport Reduces Diagnosis Time and Cost — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2294274 — (tier: 1)
- [S2] India Speeding Towards TB Elimination / 100-Day Campaign updates — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244661 — (tier: 1)
- [S3] Update on National TB Elimination Programme — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2080069 — (tier: 1)
- [S4] Shri Mansukh Mandaviya launches i-Drone, ICMR's drone-based vaccine delivery model — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1760806 — (tier: 1)
- [S5] Global Tuberculosis Report 2025 — https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025 — (tier: 2)
- [S6] Global gains in tuberculosis response endangered by funding challenges — https://www.who.int/news/item/12-11-2025-global-gains-in-tuberculosis-response-endangered-by-funding-challenges — (tier: 2)